Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港)) is an enterprise based in China. Its main office is in Shanghai. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. It was incorporated on April 01, 2026. The total number of employees is currently 101 - 500 (2025). From the latest financial highlights, Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港)) reported a net sales revenue increase of 75.41% in Q2C2025. There was a total growth of 28.78% in Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港))’s total assets over the same period. The net profit margin of Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港)) increased by 45.29% in 2025.
Headquarters
502-1 Want Want Plaza, 211 Shimen Yi Road, Jing'An District, Prc
Shanghai; Shanghai;
Contact Details: Purchase the Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港)) report to view the information.
Website: http://www.ocumension.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service